Achieving Routine Intervention and Screening for Emotional Health
Launched by UNIVERSITY OF CHICAGO · Mar 13, 2025
Trial Information
Current as of November 10, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how screening for emotional health and providing support can help people with type 2 diabetes manage their condition better. It specifically looks at diabetes distress, which is the emotional struggle that can come with managing diabetes. The goal is to see if these interventions make a positive difference for patients dealing with the challenges of their diabetes.
To participate in this trial, you need to be an adult aged 18 or older, have type 2 diabetes, and have an A1C level greater than 8%, which indicates that your blood sugar levels have been higher than recommended. Unfortunately, pregnant individuals cannot participate. If you join the study, you will take part in screenings to assess your emotional health and receive support tailored to your needs. This trial is currently not recruiting participants, but it aims to help improve emotional support for those living with diabetes in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient at a participating clinic
- • Type 2 diabetes
- • Adult (18 years or older)
- • A1C \> 8%
- Exclusion Criteria:
- • Pregnant
About University Of Chicago
The University of Chicago is a prestigious research institution renowned for its commitment to advancing medical science through innovative clinical trials. With a robust infrastructure that supports multidisciplinary collaboration, the University actively engages in cutting-edge research across various therapeutic areas. Its dedicated team of experienced investigators and state-of-the-art facilities enable the University of Chicago to conduct rigorous clinical studies aimed at improving patient outcomes and translating scientific discoveries into tangible healthcare solutions. The institution prioritizes ethical standards and patient safety, ensuring that all trials adhere to the highest regulatory guidelines and best practices in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Arshiya Baig, MD, MPH
Principal Investigator
University of Chicago
Danielle Hessler Jones, PhD
Principal Investigator
University of California, San Francisco
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported